We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Current Status and Issues of the Japan Oncofertility Registry.
- Authors
Shigematsu, Kosuke; Shimizu, Chikako; Furui, Tatsuro; Kataoka, Shinsuke; Kawai, Kiyotaka; Kishida, Toru; Kuwahara, Akira; Maeda, Naoko; Makino, Azumi; Mizunuma, Naoki; Morishige, Ken-ichirou; Nakajima, Takako Eguchi; Ota, Kuniaki; Ono, Masanori; Shiga, Naomi; Tada, Yuma; Takae, Seido; Tamura, Nobuko; Watanabe, Chie; Yumura, Yasushi
- Abstract
Purpose: Fertility preservation (FP) is becoming increasingly common among child, adolescent, and young-adult (CAYA) patients with cancer. However, Japan has long lacked definite estimates of utilization rates for FP services among CAYA patients with cancer, and little is known about disease/FP outcomes among users. Therefore, the Japan Society for Fertility Preservation (JSFP) launched the Japan Oncofertility Registry (JOFR) in 2018 and started the online registration of information regarding primary disease, FP, and data on prognosis and pregnancy outcomes. This study reports the analytical results of FP data registered in the JOFR as of 2021. Methods: Data about patients' primary disease(s), treatment courses, cancer and pregnancy outcomes, and specific procedures were extracted from the JOFR and analyzed. Results: In 2021, 1244 patients received counseling or treatment related to FP (540 males, 704 females). While the numbers of males in each age group were approximately equal, most females were aged between 31 and 40 years. In total, 490 male and 540 female patients underwent FP procedures. Leukemia, testicular cancer, and malignant lymphoma accounted for the majority of male cases seeking treatment, whereas breast cancer was the primary disease in two-thirds of the females. Since 1999, 395 patients have accumulatively experienced subsequent pregnancy. Conclusions: As of January 2022, >7000 cases from >100 fertility facilities have been registered in the JOFR. In the future, maintaining JOFR to disseminate information on cancer prognoses, pregnancy rates, and other oncofertility outcomes is expected to drive further expansion of oncofertility services in Japan.
- Subjects
JAPAN; BREAST cancer prognosis; REPORTING of diseases; EMBRYOS; HORMONE therapy; SEMEN; OVUM; LEUKEMIA; MEDICAL care use; CANCER patients; TUMORS in children; PRESERVATION of organs, tissues, etc.; PREGNANCY outcomes; FERTILITY preservation; TESTIS tumors; HUMAN reproductive technology; RESEARCH funding; LYMPHOMAS; HEMATOPOIETIC stem cell transplantation; CANCER patient medical care; CRYOPRESERVATION of organs, tissues, etc.; CHILDREN
- Publication
Journal of Adolescent & Young Adult Oncology, 2023, Vol 12, Issue 4, p584
- ISSN
2156-5333
- Publication type
Article
- DOI
10.1089/jayao.2022.0110